US Stock MarketDetailed Quotes

ABCL AbCellera Biologics

Watchlist
  • 2.034
  • -0.056-2.70%
Trading Apr 7 14:11 ET
605.99MMarket Cap-3.70P/E (TTM)

About AbCellera Biologics Company

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

Company Profile

SymbolABCL
Company NameAbCellera Biologics
Listing DateDec 11, 2020
Issue Price20.00
Founded2012
CEODr. Carl L.G. Hansen, PhD
MarketNASDAQ
Employees596
Fiscal Year Ends12-31
Address150 West,4th Avenue
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV5Y 1G6
Phone1-604-559-9005
Websitehttp://www.abcellera.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Carl L.G. Hansen, PhD
  • Chairman of the Board, President and Chief Executive Officer
  • 714.94K
  • Tryn Stimart
  • Chief Legal Officer, Chief Compliance Officer, Corporate Secretary and Privacy Officer
  • 667.69K
  • Andrew Booth
  • Chief Financial Officer and Principal Accounting Officer
  • 674.56K
  • Dr. Veronique Lecault, PhD
  • Director and Chief Operating Officer
  • 650.59K
  • John S. Montalbano, C.F.A.
  • Independent Director
  • 77.50K
  • Dr. Michael Hayden
  • Lead Independent Director
  • 105.00K
  • Dr. Andrew W. Lo, PhD
  • Independent Director
  • 55.00K

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
QIULE SEEDS
831087
+29.98%
OFDY
839371
+29.97%
KANGNONG SEED
837403
+24.50%
4
Hainan Shennong Seed Industry Technology
300189
+20.06%
5
Ningxia Xiaoming Agriculture&Animal Husbandry
300967
+20.02%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Trump's comeback to the Office

Following Trump's Policies to Seek Investment Opportunities

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025